Categories
Business

Sales of Low Vision Devices Is Expected to Surpass a Valuation of US$ 7,170.2 Mn By the End of 2026

Technological advancements, combined with adequate research and development, has led to a significant development in assistive technologies. The introduction of electronic mobility aids like Ray and UltraCane have led to incredible developments in the assistive technologies for visually impaired market.

Driven by these technological advancements, the assistive technologies demand for visually impaired market is projected to grow impressively, registering a CAGR of 8.6% during the forecast period (2020-2026). Other drivers, such as increasing geriatric population, rising cases of visual impairment and increase in healthcare expenditure shall also augment the demand for assistive technologies for the visually impaired. On this premise, the market is expected to surpass a valuation of US$ 7,170.2 Mn by the end of 2026.

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4635

Assistive Technologies Demand for Visually Impaired Market segmentation

Fact.MR has studied the assistive technologies demand for visually impaired market with detailed segmentation on the basis product type, end-users and key regions.

Product Type
  • Educational Devices & Software:
  • Braille Duplicators & Writers
  • Braille Computers
  • Mathematical & Science Devices
  • Reading Machines
  • Mobility Devices:
  • Canes
  • Low Vision Devices:
  • Smart Glasses
  • VTS Link
  • Magnifying Lenses
  • Others
End-users
  • Blind Schools
  • Enterprises & Social Organizations
  • Personal Use
  • Federation & Hospitals
  • Others
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4635

Key Takeaways of Assistive Technologies Demand for Visually Impaired Market Study

  • Product-wise, the educational devices & software segment shall constitute the maximum share of the assistive technologies demand for visually impaired market. Projections indicate a market share of around 58%. This is due to increased spending on education by public and private entities.
  • Mobility devices are expected to catch up, owing to introduction of new technologies such as Wayband, Dot Smartwatch and Be My Eyes. The segment shall expand at a CAGR of 8.8% during the forecast period.
  • Regionally, the assistive technologies demand for visually impaired market shall be dominated by North America. High adoption of technologically advanced devices and easy access by people are cited as key reasons. Projections indicate a market share of approximately 40%.
  • Asia-Pacific shall exhibit remarkable progress during the forecast period. The region shall surpass a valuation of US$ 1,649.2 Mn by the end of 2026. Increased adoption of technological devices in the educational sector such as braille translators, reading machines, magnifiers and mobility devices are considered key drivers propelling the market growth.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4635

“The assistive technologies demand for visually impaired market demonstrates prolific growth in the future. Rising adoption of computerized technology in education and mobility are expected to leverage prospects for the market,” infers a Fact.MR analyst.

assistive technologies demand for visually impaired market 01

Product Launches to Shape Assistive Technologies Demand for Visually Impaired Market Landscape

New product launches with technological advancements constitute the main strategy of key market players. Dolphin Computer Access Ltd, a British company, is set to promote its Connect & Learn, Whiteboard Wizard and EasyReader technologies at the upcoming VIEW 2020 Conference in Birmingham, Ireland. Consisting of Qualified Teacher of the Visually Impaired (QTVI) driven innovations, these platforms shall aim to provide quality education to low-vision learners. Similarly, Access Ingenuity provides technology solutions in the form of vision enhancing products like large print keyboards. These keyboards, titled ZoomText and Keys-U-See, provide large-sized alphabets to assist people with poor vision. The second invention, Victor Reader Trek, provides audio recordings of books to help readers enjoy the reading experience.

For More Insights
https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Looking for more information?

The research study on the Assistive Technologies Demand for visually impaired market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the Assistive Technologies Demand for Visually Impaired market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of product type (Educational Devices & Software, Mobility Devices, Low Vision Devices and Others) and end users (Blind Schools, Enterprises & Social Organizations, Personal Use, Federation & Hospitals and Others) across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.comContent Source: https://www.factmr.com/media-release/1396/global-assistive-technologies-demand-for-visually-impaired-market

Categories
Business

Cell-Based Flow Cytometry Is Projected to Account for Three-Fifth of the Total Market :Report Fact.MR

Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction. Moreover, flow cytometry is being increasingly used in stem-cell research where scientists examine cell conversions.

On the back of the aforementioned factors, the demand for flow cytometry is set to get leveraged in the future. A staggering CAGR of 11.4% is projected for the forecast period 2020-2025, and the market is anticipated to surpass a valuation of US$ 8,119.6 Mn by the end of the forecast period.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

Global Flow Cytometry Market Segmentation

Fact.MR has studied the global flow cytometry market with detailed segmentation on the basis of technology, products & services, application, end-users and key regions.

Technology
  • Cell-based
  • Bead-based
Products & Services
  • Reagents & Consumables
  • Flow Cytometry Instruments
  • Software
  • Services
Application
  • Pharmaceutical & Drug Discovery
  • Diagnostics
End-users
  • Pharmaceutical & Drug Discovery
  • Diagnostics
Key Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Takeaways of Global Flow Cytometry Market Study

  • Cell-based flow cytometry shall dominate the flow cytometry market, projected to account for three-fifth of the total market during the forecast period. The ease of developing models of interconnected cellular pathways for scientists is a major driver behind the segment’s growth.
  • Products & Services-wise, the flow cytometry instruments shall constitute a major chunk of the flow cytometry market. Projections indicate a market share of around 40% for flow cytometry instruments between 2020 and 2025. Greater usage of advanced flow cytometry instruments in novel drug discovery is boosting the market.
  • Pharmaceutical and drug discoveries shall find maximum application of flow cytometry in the future. This is attributed to increased research and development activities by major pharmaceutical companies for therapeutic drug development. The segment is anticipated to hold a market share of around 45% during the forecast period.
  • Academic & Research Institutions are expected to find maximum usage of flow cytometry. The segment is expected to grow staggeringly at a CAGR of 11.6% during the forecast period. Increased research for novelty, efficacy, toxicity and safety of medicines are major drivers for the growth of this segment.
  • North America shall dominate the global flow cytometry market during the forecast period, accounting for more than one-third of the total flow cytometry market. Government campaigns to increase awareness about chronic diseases and increased research and development are factors augmenting the market growth in the region.
  • However, Asia-Pacific is expected to register stellar growth during the forecast period, expanding at a CAGR of 14%. A burgeoning pharmaceutical industry, development of new biologics, vaccines and drugs are expected to leverage future growth of the flow cytometry market.

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4633

global flow cytometry market 1

“The global flow cytometry market shows immense potential for future growth. The widespread application of flow cytometry in important life science disciplines such as cancer detection and stem cell research is expected to boost the global flow cytometry market’s prospects in the future”, concludes a Fact.MR analyst.

Acquisitions to Supplement Market Growth

The global flow cytometry market is dominated by the following players:

  • Becton Dickinson & Company.
  • Merck & Co.Inc.
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • SYSMEX CORPORATION
  • Alere Inc.
  • Miltenyi Biotec
  • Bio-Techne
  • Agilent Technologies Inc. 
  • Bio-Rad Laboratories Inc.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4633

Looking for more information?

The research study on the global flow cytometry market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global flow cytometry market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Technology (Cell-based and Bead-based), Products & Services (Reagents & Consumables, Flow Cytometry Instruments, Software and Services), Application (Pharmaceutical & Drug Discovery, Diagnostics and Others) and End-Users (Hospitals & Diagnostic Labs, Academic & Research Institutions and Others) across five major regions.

Report Benefits & Key Questions Answered

  • Flow Cytometry Company & brand share analysis: The report offers brand-share analysis on Flow Cytometry market to offer a more in-depth competition deep-dive. This is intended at assisting companies at proactive long-term planning.
  • Flow Cytometry Historical volume analysis: Factors affecting sales in the past are analyzed in detail. The report also offers comparative analysis between growth trajectory exhibited in 2016-2020 and 2020-2025.
  • Flow Cytometry Category & segment level analysis: To offer a comprehensive analysis, the market identifies leading segments and highlights chief factors enabling growth across these categories.
  • Flow Cytometry Consumption by demographics: The demographic analysis is intended at providing recommendations to companies to help them create growth strategies around dynamic consumption patterns.
  • Flow Cytometry Manufacturing trend analysis: Manufacturing trend analysis is the key highlight of the study. It offers vital data on strategies adopted by market players to align their manufacturing strategies as per prevailing market trends.            

Get More Insights

https://www.biospace.com/article/facial-spasm-treatment-demand-augmented-by-growing-awareness-of-the-treatment-options-says-fact-mr

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.comContent Source: https://www.factmr.com/media-release/1395/global-flow-cytometry-market

Categories
Pharmaceutical

Traditional Chinese Medicine for Skincare Market will surpass US$ 7 billion in valuation by 2031

Demand for traditional Chinese medicine for skincare is increasing steadily owing to the rising popularity of Chinese herbal medicines and similar products. With growing application in eczema, psoriasis, acne, and others, manufacturers of traditional Chinese skincare medicine are expected to gain higher revenues over the coming years.

As per a new report by Fact.MR, North America, Europe, and Asia Pacific will hold major chunk of the industry value and volume, while the United States, Germany, China, and a few other countries will offer significant opportunities for stakeholders in this industry, across regions.

For more insights into the Market, Request a Sample of this Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=5806

Key Takeaways from Market Study
  • High demand for Chinese herbal medicines for body care, face care, and others likely to be witnessed.
  • Growing application in eczema and psoriasis to cater to industry growth.
  • The United States to remain the epicenter of North America’s market for traditional Chinese medicine for skincare.
  • Germany to lead in Europe as far as traditional Chinese medicine for skincare is concerned.
  • Asia Pacific to exhibit the fastest growth in the market.
  • China, Japan, India, Canada, the United Kingdom, and South Korea to maintain positive industry outlook throughout the forecast period.
“Advancements in manufacturing, growing investments in R&D activities, and prominent demand for acupuncture, diet therapy, and various Chinese herbal medicines are expected to boost the sales of manufacturers over the coming years,”

says a Fact.MR analyst.

traditional chinese medicine for skincare market

 

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5806

Rising Prevalence of Skin Diseases Bolstering Demand for Traditional Chinese Medicine

Various traditional medicines for face care, body care, and foot & hand care are extensively being used for a diverse range of skin diseases such as eczema, psoriasis, hyperpigmentation, and acne, to name a few. As a result, rising prevalence of such diseases and skin-related issues is augmenting demand for traditional Chinese medicines, especially for skincare purposes.

According to a report titled “Burden of Skin Disease”, published by the American Academy of Dermatology, approximately 84.5 million Americans, which means one in four Americans, are affected by some kind of skin disease. According to the National Center for Biotechnology Information (NCBI), in Europe, some of the most common skin diseases are warts (41.3%), followed by acne (19.2%), and contact dermatitis (15%), as of 2018. This, in turn, is fuelling the sales traditional Chinese skincare medicine across geographies.

Who is Winning in this Space?

With the competition getting stricter, manufacturers of traditional Chinese medicine for skincare are launching a wider variety of quality products.

For instance,

  • Integrated Chinese Medicine Holdings Ltd. recently launched its new range of Qianding Yunzhi, Qianding Yunzhi Family Pack, and others.
  • Solstice Medicine Company, Inc. launched its new range of Beanne Extra Pearl Cream, Sanjin Uroplex Tablets, and others, a couple of years back.

Get More Insights- https://www.prnewswire.com/news-releases/versatility-of-traditional-chinese-medicines-make-it-highly-sought-after-in-skincare-fact-mr-301288790.html

More Valuable Insights

In its latest report, Fact.MR offers an unbiased analysis of the traditional Chinese medicine for skincare market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (Chinese herbal medicines [body care, face care, and foot & hand care], acupuncture, and diet therapy), and application (eczema, psoriasis, acne, hyperpigmentation, and others), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Explore Fact. MR’s Coverage on Healthcare Domain

Skincare serum market: The global skincare serum market report published by Fact.MR offers an exhaustive analysis on the prominent growth dynamics, including possible drivers, opportunities and challenges, expected to prevail across the landscape for the upcoming decade. A detailed insight regarding key geographies and prominent manufacturers has been embedded in this report.

OTC herbal and traditional medicine Market: Fact. MR’s latest report on global OTC herbal and traditional medicine market gives a detailed insight on the key drivers, trends and opportunities expected to prevail across prominent segments and key geographies for the forthcoming assessment period. Additionally, details about prominent manufacturers and their revenue shares have also been incorporated.

Geriatric medicine Market: The latest report by Fact.MR on global geriatric medicine market offers an unbiased analysis on the growth prospects, strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/traditional-chinese-medicine-for-skincare-market
Press Release: https://www.factmr.com/media-release/1950/global-traditional-chinese-medicine-for-skincare-market

Categories
Pharmaceutical

North America followed by Europe is expected to Lead the Ultrasound Systems Market in Terms of Revenue Growth, Reveals Fact.MR Study

Demand for standalone and tabletop ultrasound systems is rising steadily, and industry players are set to witness increase in revenue over the coming years. 2D ultrasound technology is expected remain extremely popular across regions, shaping the expansion strategies of market players.

The latest revised market study by Fact.MR offers a holistic overview of the global industry along with its driving and restraining factors and demand-supply trajectories for the forecast period of 2021 to 2031. As stated in the report, the global ultrasound systems will ascend at over 6% CAGR topping a valuation of US$ 8.5 billion in 2031.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=60

What are the Key Challenges Faced by Ultrasound System Suppliers?

Despite having high demand, suppliers of ultrasound systems face a few restraining factors, such as-

  • Expensive production process
  • Complex process cycle
  • Requirement for expert handling
  • Additional operational & maintenance costs

However, the overall advantages of ultrasound systems outweigh these restraints, and hence, ultrasound system providers are expected to experience lucrative growth scope in the foreseeable future.

“Technical advancements in the manufacturing sector coupled with incorporation of high-intensity focused ultrasound and extracorporeal shockwave lithotripsy is expected to augment demand growth for ultrasound systems,” says a Fact.MR analyst.
ultrasound systems market
Demand from Hospitals & Diagnostics Centers to Remain High

Ultrasound systems are extensively used in examining internal body organs such as-

  • Liver
  • Kidneys
  • Bladder
  • Spleen
  • Pancreas

With increase in demand from hospitals and diagnostic centers, manufacturers of ultrasound systems are expected to come across huge opportunities in the foreseeable future.

Get Customization on this Report for Specific Country
https://www.factmr.com/connectus/sample?flag=RC&rep_id=60

According to a report titled “Medical Technology Industry Spotlight”, published by Select USA, the United States healthcare and medical devices industry is worth US$ 156 billion, which represents 40% of the global industry. As stated in the report, the U.S. healthcare and medical devices industry is set to reach US$ 208 billion by 2023. This gives a glimpse of the growing opportunities for ultrasound system manufacturers not only in the U.S. but across the globe.

Who is Winning in this Space?

The global ultrasound systems market offers a highly competitive environment to its players. In order to capitalize on the growing opportunities, key industry players are emphasizing on the quality and quantity of products.

For instance,

  • General Electric Company recently launched its new Handheld Ultrasound System Vscan, Point of Care Ultrasound, Vivid Ultra Edition Solutions, and others.
  • Toshiba Corporation launched its new Apollo i-series, Apollo a-series, Xario Platinum Series, and others a couple of years back.
More Valuable Insights

In its latest report, Fact.MR offers an unbiased analysis of the ultrasound systems market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of portability (standalone ultrasound systems, table-top ultrasound systems, and portable ultrasound systems), end user (hospitals, diagnostic centres, ambulatory surgical centres, and others), application (cardiology, radiology, urology, vascular, gynaecology, and others), and technology (2D ultrasound, 3D & 4D ultrasound, high-intensity focused ultrasound, and extracorporeal shockwave lithiotripsy), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Get More Insights- https://www.prnewswire.com/news-releases/ultrasound-systems-sales-will-continue-growing-spurred-by-applications-in-cardiology-factmr-301282160.html
Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/60/ultrasound-systems-market
Press Release: https://www.factmr.com/media-release/1911/ultrasound-systems-market-trends

Categories
Pharmaceutical

Cost Benefits of Artificial Insemination In Asia Pacific are Attracting Reproductive Care Seekers from Across the Globe: Fact.MR

250 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of Assisted Reproductive Technology Market Over the Forecast Period 2020-2025

The Fact.MR study on the assisted reproductive technology market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Procedure ( Frozen Donor, Frozen Non-Donor, Fresh Donor) , End User (Fertility Clinics, Hospitals), and Technology (In Vitro Fertilization, Artificial Insemination, Surrogacy). The report also highlights the scope of assisted reproductive technology over the assessment period

In-vitro fertilization (IVF) technology would account for an unrivalled patient base, as compared to surrogacy and artificial insemination, on the back of the high success rate of the procedure. The introduction of preimplantation genetic diagnosis (PGD) technology helps medical professionals screen embryos for inherited diseases, which further improves the prospects of conceiving a healthy child.  Conditions such as PCOD/PCOS are found to worsen the reproductive performance of women, which leads to remote chances of conceivability, thereby encouraging women to undergo infertility treatment using assisted reproductive technology. Based on these relevant insights, authors of an exclusive Fact.MR study estimate a CAGR of around 6.3% for the expansion of the assisted reproductive technology market during the forecast period (2020-2025).

Improvement in Predictive Analytics Across Healthcare is Driving the Growth Of Assisted Reproductive Technology Market

Increasing awareness regarding the individual’s health coupled with the ongoing advancement in healthcare infrastructures such as improvement in data science and predictive analytics are creating lucrative growth opportunities for the Assisted Reproductive Technology market.

A subject matter expert at Fact.MR opines, “Currently, Europe, North America, Latin America, and a handful of countries in the Asia Pacific and the Middle East & Africa have regulations protecting the legal rights of the homosexual populace. However, homosexually-close relationships are progressively gaining acceptance in other countries too, which is indicative of the high demand for assisted reproductive technology in future.”

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=4393

Assisted Reproductive Technology Demand Analysis by Category

Procedure
  • Frozen Donor
  • Frozen Non-donor
  • Fresh Donor
  • Fresh Non-donor
  • Embryo Banking
Technology
  • In-vitro Fertilization
    • Intra-cytoplasmic Sperm Injection (ICSI)
    • Preimplantation Genetic Diagnosis (PGD)
  • Surrogacy
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
    • Others
  • Others
End User
  • Fertility Clinics
  • Hospitals
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa


Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4393

Key Highlights of Assisted Reproductive Technology Market Study

  • High costs associated with quality IVF and IUI procedures are gradually propelling a shift of patients from assisted reproductive technology towards naturopathic solutions and alternative therapies to treat infertility, which is posing as a threat to developmental efforts of market players.
  • Increasing number of dual working households with a career-intensive approach, in turn, continues to increase reproductive complexity, which is taken into account by major corporates. Efforts have been made by major companies, such as Google LLC, towards creating a conducive environment for female employees by offering facilities to store their eggs, thereby stimulating growth of the assisted reproductive technology market.
  • Initiatives taken by numerous public and private institutions such as ASPIRE are projected to raise awareness and increase the adoption of assisted reproductive technology in Asia Pacific. Public awareness campaigns are also being witnessed in the U.S. by central authorities such as the Society for Assisted Reproductive Technology and National Infertility Association, which is reflecting on the growing patient base for infertility treatment.
  • Cost benefits of artificial reproductive techniques in developing countries of Asia Pacific are attracting reproductive care seekers from across the world. The study finds that, a complete package of surrogacy costs merely one-third of that in the U.K., which is strengthening the position of Asia Pacific as a key surrogacy destination.

Full Access of this Report Is Available At 

https://www.factmr.com/checkout/4393

Cost-effectiveness of Alternative Medicines to Remain Pertinent Threat for Players

Numerous threats and challenges with varying influence are encountered by players in the assisted reproductive technology market, including threats of cost-effective alternative therapies and choice of child adoption. Though entry barriers in the assisted reproductive technology are high, on the back of huge CAPEX and OPEX requirements, intense development activities undertaken by existing players are influential enough to turn the landscape fragmented. For instance, a key player—Nidacon International AB—focuses on product innovation in the sperm diagnostic segment, and, in turn, extends efforts towards upgrading its existing product lines. Collaborations and alliances among leading players are also projected to foster improvements in fertility techniques, thereby leading to advancements in assisted reproductive technology.

Find More Valuable Insights on Assisted Reproductive Technology Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global assisted reproductive technology market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the assisted reproductive technology market on the basis of technology (in-vitro fertilization, surrogacy, artificial insemination, and others), procedure (frozen donor, frozen non-donor, fresh donor, fresh non-donor, and embryo banking), and end user (hospitals, fertility clinics, and others), across five major regions in the assisted reproductive technology market.

For More Insights 

https://www.biospace.com/article/legalization-and-strict-regularization-of-medical-cannabis-is-pivotal-for-improved-uptake-of-cannabis-analyzer-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Recombinant Protein Immune Checkpoint Regulators Market Is Estimated to Account for Nearly US$ 460 Mn Revenues by 2022-end

250 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of Recombinant Protein Market Over the Forecast Period 2017-2022

The Fact.MR study on the recombinant protein market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Product Type (Immune Checkpoint Regulators, Chemokines ), End Users ( Biopharmaceutical Companies, Contract Research Organizations ). The report also highlights the scope of recombinant protein over the assessment period

A new report published by Fact.MR estimates the global sales of recombinant protein to witness expansion at a moderate CAGR during the forecast period 2017 to 2022. Revenues from the global recombinant protein market will reach nearly US$ 460 Mn by 2022-end.

Through genetic engineering, and cell engineering, recombinant protein are produced from creature body. The recombinant protein technology now stands at the edge of biotechnology production. Becoming the new standard, this technology is witnessing a gradual shift from bulk production procedure towards post-production techniques, which in turn promises an enhanced delivery and stability. The highly effective recombinant proteins play an integral part in treating specific diseases, such as hemophilia. However, blood coagulation factor is excluded, as it possesses an extremely limited source.

A large number of recombinant protein drugs utilized are human proteins. This is mainly to compensate functional proteins in vivo defects, and for increasing the functions of proteins in a body. These factors provide recombinant proteins with substantially higher safety as compared to small molecules, further leading towards higher approval rates.

For More Insights Into The Market, Request a Sample of this Report 

https://www.factmr.com/connectus/sample?flag=S&rep_id=186

The clinical trial periods for recombinant proteins are comparatively shorter than small molecule drugs, which further aids in enhancing patient protection, and renders pharmaceutical companies with a relatively longer exclusive sales time. Factors such as these are driving the development, and demand for recombinant proteins. Recombinant proteins target diseases such as cardiovascular diseases, endocrine diseases, viral diseases, and cancer.

In addition, the global recombinant protein market has a larger extension space, with few approval drugs available without any alternative products in therapeutic areas. These factors might influence growth of the market over the forecast period. However, factors such as technical barriers, financial barriers have made recombinant protein technology expensive. Moreover, replication of recombinant proteins incurs many challenges, as compared to replication of small molecule chemicals. These factors may impede growth of the market in the near future.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=186

Recombinant Protein Demand Analysis by Category

Product Type

  • Immune Checkpoint Regulators
  • Chemokines
  • Growth Factors
  • Cytokines
  • Colony Stimulating Factors
  • Hormones
  • Enzymes & Inhibitors

End User

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Forensic Science Laboratories
  • Food & Beverage Companies
  • Diagnostic Centers

Application

  • Drug Discovery & Development
  • Basic Research
  • Toxicity Screening
  • Biopharmaceutical Production
  • Drug Screening
  • Tissue Engineering
  • Forensic TestingBasic research will remain the largest application segment in the global recombinant proteins market. Revenues from basic research will reach roughly US$ 270 Mn in revenues by the end of 2022.

Full Access of this Report Is Available At 

https://www.factmr.com/checkout/186

Key Recombinant Protein Survey Highlights and Projections

  1. Toxicity screening, and drug discovery & development will witness the fastest expansion through 2022, based on application of recombinant proteins.
  2. Recombinant protein sales for forensic testing application will exhibit the lowest CAGR in the market through 2022.
  3. North America is projected to remain dominant in the global market for recombinant proteins, with sales poised to account for approximately US$ 150 Mn revenues by 2022-end.
  4. Europe will continue to be the second largest market for recombinant proteins over the forecast period.
  5. The market for recombinant protein in Middle East & Africa (MEA) will exhibit a sluggish expansion through 2022.
  6. Academic & research institutes will remain the most lucrative end-users in the global recombinant proteins market, accounting for more than one-third revenue share of the market throughout the forecast period.
  7. Biopharmaceutical companies will continue to be the fastest expanding end-users of recombinant proteins in the global market.
  8. Although growth factors are estimated to remain the largest product segment, sales of chemokines will register the fastest expansion through 2022.

For More Insights

https://www.biospace.com/article/how-demand-for-renovascular-hypertension-treatment-growth-spurred-by-increasing-prevalence-of-kidney-disorders-opines-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Adoption of Drug Eluting Balloon Catheter to Surge Owing to the Increased In Demand for the Treatment of Coronary Artery Disease

Fact MR analysis of Drug Eluting Balloon Catheter market provides compelling insights into the factors propelling sales prospects in key segments such as Indicatione (Coronary Artery Disease,Peripheral Vascular Diseas), End User ( Hospitals,Ambulatory Surgical Centers,Cardiac Catheterization Laboratories), and Raw Material ( Polyurethan,Nylon). It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

Drug eluting balloon catheter is witnessing robust adoption owing to its overwhelming results in cardiovascular and peripheral artery procedures. Moreover, drug eluting balloon catheter is also turning out to be useful for patients who are unable to undergo percutaneous coronary intervention (PCI) procedures.

Encouraged by this situation, various drug eluting balloon catheter manufacturers across the globe are now increasing their production capacity. The aforementioned factors are reflecting favorably on the global sales of the drug eluting balloon catheter.

Also, companies are aiming to manufacture cost-effective catheters in order to increase market penetration. The growing prevalence of cardiovascular diseases and soaring incidences of cardiology intervention procedures is facilitating the growth of the global drug-eluting balloon catheter market.

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=146

Improvement in Predictive Analytics Across Healthcare is Driving the Growth Of Drug Eluting Balloon Catheter Market

Increasing awareness regarding the individual’s health coupled with the ongoing advancement in healthcare infrastructures such as improvement in data science and predictive analytics are creating lucrative growth opportunities for the Drug Eluting Balloon Catheter market.

Fact.MR projects that the global market for drug eluting balloon catheter will surge at a robust CAGR between 2018 and 2022. In addition, factors such as enhanced reimbursement policies, rising geriatric population, and growing healthcare expenditure are anticipated to positively impact the market’s growth.

The arrival of new-generation drug eluting balloon catheters as well as heavier investments in R&D pipelines in order to increase its utility is also anticipated to create lucrative growth opportunities for manufacturers and stakeholders in the global market for drug eluting balloon catheters.

Market Taxonomy

Indicatione
  • Coronary Artery Disease
  • Peripheral Vascular Diseas
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Raw Material
  • Polyurethane
  • Nylon
  • Others

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=146

Key Insights From the Report Include: 

  • Among regions, Europe will retain its dominant position in the market over the forecast period. Between 2017 and 2022, the drug eluting balloon catheter market in Europe will reflect a CAGR of 20.5%. Meanwhile, the Asia-Pacific excluding Japan (APEJ) market will also witness robust growth over the next couple of years.
  • By indication, drug eluting balloon catheter will be used mostly for treating coronary artery disease. Currently, the coronary artery disease indication segment will command for more than two-third revenue share of the global market.
  • Hospitals will remain the largest end-user of drug eluting balloon catheter in 2017 and 2022. Sales of drug eluting balloon catheter currently command for close to 73% market share in terms of revenue. Hospitals are one of the most preferred medical settings for undertaking coronary artery and restenosis procedures.
  • By raw material, demand nylon-based drug eluting balloon catheter will continue to gain traction over the assessment period. Currently, sales of nylon-based drug eluting balloon catheter account for close to 54.1% revenue share of the global market. Towards the end of 2022, more than US$ 244 Mn worth of nylon drug eluting balloon catheters are expected to be sold worldwide.

Full Access of this Report Is Available At

https://www.factmr.com/checkout/146

Competition Tracking

  • Cardionovum GmbH
  • Cook Medical INC
  • Cordis Corporation
  • Abbott Laboratories
  • Meril Life Sciences Pvt Ltd
  • Jotech GmbH
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Boston Scientific Corporation
  • Tokai Medical Products Inc.
  • BIOTRONIK SE & Co. KG
  • B. Braun Melsungen AG
  • Medtronic Plc.

For More Insights

https://www.biospace.com/article/emergence-of-pharma-tech-and-new-product-launches-is-driving-growth-of-global-analytical-gel-permeation-chromatography-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Orthopedic Implants to Record a CAGR of 6.5% over the Forecast Period by 2027

250 Pages Orthopedic Implants Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

Fact MR analysis of the orthopedic implants market provides compelling insights into the factors propelling sales prospects in key segments such as Product Type, Fixation Type, and End User. It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

The orthopedic implants market continues to be a promising avenue in the global medical technology space. Emergence of advanced technologies coupled with rise in orthopedic disorders are major growth determinants for the orthopedic implants market. A recent report by Fact.MR envisions the demand for orthopedic implants to record an august 6.5% CAGR over the forecast period 2018 to 2027.

Although surgeries of orthopedic implants incorporating robotics offer reproducible precision and are less invasive, expensiveness of the technology coupled with the requirement for robust, evidence-based studies continues to impede its adoption in orthopedic surgeries.

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=990

orthopedic implants market

Global Orthopedic Implants Market: Segmentation

By Product Type

Hip Reconstruction
Knee Reconstruction
Shoulder Implants

By Fixation Type

Cement
Cementless
Hybrid

By End User

Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers

Digital Transformation in Healthcare Presenting Opportunities for Orthopedic Implants Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Orthopedic Implants market.

Following Questions Answers Covered in the Report are:

  • How will the global Orthopedic Implants Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Orthopedic Implants Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Orthopedic Implants Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=990

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –http://www.globenewswire.com/en/news-release/2018/07/06/1534093/0/en/Pet-Wearables-Market-to-Surpass-a-Valuation-of-US-3-463-Mn-Over-2022-Finds-Fact-MR.html

Revenues from sales of orthopedic implants for hip reconstructed exceeded US$ 16,800 Mn in 2017.

North America’s preeminent in the orthopedic implants market will continue to prevail, states Fact.MR study. According to American Joint Replacement Registry (AJRR), over 7 million America have been associated with knee and hip reconstruction surgeries collectively. Over half revenue share of the market will be accounted by orthopedic implants sales in North America by 2027-end.

The U.S. Food and Drug Administration (FDA) has approved a slew of robotic surgery systems for orthopedic implants, with the da Vinci Surgical System being the first one. More companies have been investing in the technology for providing a better navigation during the procedure, and obtain 3D scans to aid designing of customized joints.

Acquisitions and mergers continue to be key strategic expansion methods adopted by companies operating in the orthopedic implants market. Acquisition of Mako Surgical Corp. by Stryker – for total hip and knee construction robotic products for orthopedic implants, and Blue Belt Holdings by Smith & Nephew for robot-assisted orthopedic implant surgery product for partial knee replacements are prime instances of such strategic expansions.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=990

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Increasing Demand for Cancer Tumor Profiling to Substantially Surge the Revenues Through 2028

250 Pages Cancer Profiling Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

Fact MR analysis of cancer profiling market provides compelling insights into the factors propelling sales prospects in key segments such as Product Type, Indication, and Test Type ,End User. It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.

Focus on improving overall patient care will remain a chief growth driver. Besides this, cancer profiling market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth potential on the basis of Product Type, Indication, and Test Type.

Request a Report Sample to Gain Comprehensive Market Insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=358

Digital Transformation in Healthcare Presenting Opportunities for Cancer Profiling Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the cancer profiling market.

cancer profiling tests price analysis us unit by region

Key Cancer Profiling Survey Highlights and Projections

Driven by higher investment in innovation, the U.S. will emerge as the dominant Cancer Profiling market in North America, accounting for 4.7% of overall sales registered in 2028.

With the presence of some of the world’s leading healthcare companies, coupled with high spending on hospital services, the U.K. and Germany will emerge as highly lucrative pockets in Europe.

Investment towards healthcare sector expansion and focus on medical tourism will make China, Japan, and South Korea key markets within East Asia.

Speak to Research Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=358

Report Benefits & Key Questions Answered

Cancer Profiling Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.

Cancer Profiling Historical volume analysis: The report provides a comparison of Cancer Profiling’s historical sales and projected sales performance for 2021-2031.

Cancer Profiling Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Cancer Profiling market. It carefully gauges the impact of changing healthcare needs of key demographics globally

Cancer Profiling Consumption by demographics: The report investigates consumer behavior affecting Cancer Profiling demand outlook for the assessment period. Effect of their keenness for digital trends on Cancer Profiling market is carefully analyzed

Post COVID consumer spending on Cancer Profiling: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Cancer Profiling market growth.

Competitive Landscape Analysis

The study offers insights into key trends affecting healthcare industry, subsequently influencing demand supply forces in the Cancer Profiling market.

  • F. Hoffmann La Roche Ltd
  • Illumina Inc
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Abbott
  • Nanostring Technologies Inc
  • Siemens AG
  • HTG Molecular Diagnostics, Inc
  • Perkin Elmer Inc
  • Agilent Technologies Inc
  • Negenomics Laboratory Inc

To offer an in-depth analysis of prevailing competition, the report offers a detailed market share analysis. In this chapter market players are segregated in terms of Tier 1, Tier 2, and Tier 3 companies. Strategies adopted by players across these categories and impact of the same on the overall market are studied at length.

Full Access of this Report Is Available at https://www.factmr.com/checkout/358

Cancer Profiling Demand Analysis by Category

Product Type

Immunohistochemistry (IHC) Analyzers
Fluorescence In situ Hybridization (FISH) Instruments
PCR instruments
DNA Sequencer
Fragment Analyzer
Consumables
Reagents & Kits
Other Ancillary (probes, holders etc.)

By Indication

Breast Cancer
Colorectal Cancer
Ovarian Cancer
Melanoma
Kidney Cancer
Lung Cancer (including NSCLC)
Rare Cancers

By End User

Hospitals
Diagnostic Centres
Cancer Research Institutes

Region

North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

For More Insights https://www.biospace.com/article/linear-motion-systems-sales-surged-by-increment-in-industrial-production-across-the-globe-says-fact-mr/

Cancer Profiling Market – Additional Questions Answered

In addition to the aforementioned insights, the cancer profiling market report delivers intelligent insights based on a thorough assessment of all the market facets. These insights can answer to some of the bemusing questions of the business professional interested in the cancer profiling market.

  • Which product type in the cancer profiling market will register significant demand by the end of the assessment period?
  • Which region presents considerable utilization of cancer profiling tools?
  • Among different test types, which test type will be highly sought after in the cancer profiling market during the forecast period?
  • Which end-user will register leading utilization of cancer profiling tests during the forecast period?

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Strong Healthcare Infrastructure Is Expected To Favour Sales Growth Of AI In Diagnostic Imaging Market

According to a recent report published by Fact.MR, the global AI in medical diagnostics market is projected to reach USD 3,868 million by 2025 from USD 505 million in 2020, at a CAGR of 50.2% during the forecast period. The goal of the AI In Diagnostic Imaging Market survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Demand for advanced technology for early diagnostic and imaging procedures is a major driving factor of the AI In diagnostic imaging market. Growth in this market is primarily driven by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and the growing number of cross-industry partnerships and collaborations.

Get in-depth analysis of the COVID-19 impact on the Artificial Intelligence (Ai) in Medical Diagnostics Market, Request a report Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=3110

Competitive Outlook

The competitive outlook chapter throws light on the business prospects of prominent players operating in the AI In Diagnostic Imaging Market. The product pricing strategies, preferred marketing channels, product portfolio of prominent players, and market presence of each company is included in the report.

AI In Diagnostic Imaging Market: Key Market Participants

Example of some market players participants in global AI in diagnostic imaging market identify across the value chain are

  • Canon Inc.,
  • GE Healthcare,
  • Siemens Healthineers,
  • DeepMind Technologies,
  • Subtle Medical Inc.,
  • Samsung Healthcare,
  • Butterfly Network Inc.,
  • Koninklijke Philips N.V. and others.

AI In Diagnostic Imaging Market: Segmentation

On the basis of product type, AI in Diagnostic Imaging market can be segmented as:

  • AI-powered Ultrasound Scanners
  • AI-powered CT Scanners
  • AI-powered MRI Systems
  • AI-powered Optical Coherence Tomography Devices
  • Others

To speak to our analyst for a discussion on the above findings, click Speak to Analyst https://www.factmr.com/connectus/sample?flag=B&rep_id=3110

On the basis of end user, AI in Diagnostic Imaging market can be segmented as:

  • Hospitals
  • Ambulatory Surgical Centres
  • Diagnostic Centres

Critical insights enclosed in the report:

  • Accurate representation of the projected growth of the global AI in medical diagnostics Market during the forecast period
  • Analysis of the distribution channels and promotional strategies adopted by market players in the AI in medical diagnostics Market
  • Assessment of the global presence of various players in the AI in medical diagnostics Market
  • An in-depth study of the supply-demand trends in different regions
  • Manufacturing/production capabilities of various players operating in the AI in medical diagnostics Market

Request for Customization of AI in medical diagnostics market – https://www.factmr.com/connectus/sample?flag=RC&rep_id=3110

Frequently Asked Questions (FAQ):

  1. What is the market size of the AI in medical diagnostics Market?

The global AI in medical diagnostics market is projected to reach USD 3,868.01 million by 2025 from USD 505.24 million in 2020, at a CAGR of 50.2% during the forecast period.

  1. What are some of the major drivers for this market?

AI in diagnostic imaging expected to grow with double-digit growth rate over the forecast period. AI in diagnostic imaging is achieving strong growth as the capability to detect cancer at an early stage and track tumor development.

  1. Who are the major players in the AI in medical diagnostics market?

Some market players participants in global AI in diagnostic imaging market identify across the value chain are Canon Inc., GE Healthcare, Siemens Healthineers, DeepMind Technologies, Subtle Medical Inc., Samsung Healthcare, Butterfly Network Inc., Koninklijke Philips N.V. and others.

  1. What is the impact of COVID-19 on the AI in medical diagnostics market?

Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities across the globe have been overwhelmed by the large number of patients visiting them on a daily basis.

  1. Which region has the highest growth potential in the AI in medical diagnostics market?

North America is the most dominating market for AI in diagnostic imaging market due to the increasing demand for artificial intelligence in the U.S. healthcare market and a large number of players in the region.

Read More Trending Reports of Fact.MR:

https://www.biospace.com/article/latest-insights-on-nano-healthcare-technology-market-post-covid-fact-mr-new-report-analyzes/

Explore Fact.MR’s Coverage on the Healthcare Domain

ACL Reconstruction Market- The growing prevalence and recurrence of injuries caused by sports is expected to be the major factor driving the growth of the ACL Reconstruction market over the forecast period.

Allergic Rhinitis Treatment Device MarketAccording to the American Academy of Allergy, Asthma & Immunology, 7.8% of people over 18 years of age in the U.S. suffer from allergic rhinitis.

Auto Disable Syringes Market The global market for auto disable syringes is consolidated with a few large players dominating the scene. The global auto disable syringes market trends include a definite shift in favor of developing regions of Asia Pacific, such as India, and China.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

 

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com